MNPR – monopar therapeutics inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

MNPR

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/22

08:12 am

mnpr

Is Monopar Therapeutics Inc. (NASDAQ:MNPR) Trading At A 46% Discount? [Yahoo! Finance]

Low Report

Is Monopar Therapeutics Inc. (NASDAQ:MNPR) Trading At A 46% Discount? [Yahoo! Finance]

Report

11/14

07:22 am

mnpr

Monopar Therapeutics (NASDAQ:MNPR) was downgraded by analysts at Raymond James Financial, Inc. from a "strong-buy" rating to an "outperform" rating.

High Report

Monopar Therapeutics (NASDAQ:MNPR) was downgraded by analysts at Raymond James Financial, Inc. from a "strong-buy" rating to an "outperform" rating.

Report

11/14

05:16 am

mnpr

Monopar Therapeutics GAAP EPS of -$0.48 misses by $0.05 [Seeking Alpha]

High Report

Monopar Therapeutics GAAP EPS of -$0.48 misses by $0.05 [Seeking Alpha]

Report

11/13

08:38 am

mnpr

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments [Yahoo! Finance]

Medium Report

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments [Yahoo! Finance]

Report

11/13

08:00 am

mnpr

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments

Medium Report

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments

Report

11/11

07:17 am

mnpr

Monopar Therapeutics (NASDAQ:MNPR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Low Report

Monopar Therapeutics (NASDAQ:MNPR) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Report

10/25

12:09 pm

mnpr

Monopar Therapeutics (NASDAQ:MNPR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Low Report

Monopar Therapeutics (NASDAQ:MNPR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.

Report

10/17

10:26 pm

mnpr

Raymond James Boosts Monopar Therapeutics (MNPR) PT to $142, Maintains Strong Buy [Yahoo! Finance]

Medium Report

Raymond James Boosts Monopar Therapeutics (MNPR) PT to $142, Maintains Strong Buy [Yahoo! Finance]

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/13/2025

08:00 am

mnpr

monopar therapeutics inc.

MISS Report

3.8%

monopar therapeutics inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

11/14

07:22 am

Downgrades

Strong-Buy

Outperform

Raymond James Financial, Inc.

High

Report

-10.4%

Report

11/14

06:52 am

Downgrades

Strong Buy

Outperform

Raymond James

High

Report

-10.4%

Report

11/14

06:52 am

Downgrades

Strong Buy

Outperform

Raymond James

High

Report

-10.4%

Report

11/14

06:05 am

Downgrades

STRONG BUY

OUTPERFORM

RAYMOND JAMES

High

Report

-10.4%

Report

11/14

06:05 am

Downgrades

STRONG BUY

OUTPERFORM

RAYMOND JAMES

High

Report

-10.4%

Report

11/13

04:14 pm

Maintains

Buy

Chardan Capital

High

Report

-10.4%

Report

10/14

07:59 am

Upgrades

Strong-Buy

Barclays PLC

Medium

Report

-8.4%

Report

10/13

08:04 am

Initiates

Overweight

Barclays

High

Report

14.2%

Report

Date

Time

Symbol

Headline

Impact

11/14

04:21 pm

mnpr

Form SCHEDULE 13G/A Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.

Low Report

Form SCHEDULE 13G/A Monopar Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P.

Report

11/14

12:50 pm

mnpr

Form SCHEDULE 13G/A Monopar Therapeutics Filed by: JANUS HENDERSON GROUP PLC

Low Report

Form SCHEDULE 13G/A Monopar Therapeutics Filed by: JANUS HENDERSON GROUP PLC

Report

11/13

08:01 am

mnpr

Form 8-K Monopar Therapeutics For: Nov 13

Medium Report

Form 8-K Monopar Therapeutics For: Nov 13

Report

11/13

08:01 am

mnpr

Form 10-Q Monopar Therapeutics For: Sep 30

Medium Report

Form 10-Q Monopar Therapeutics For: Sep 30

Report

10/2

03:05 pm

mnpr

Form 4 Monopar Therapeutics For: Sep 30 Filed by: Cittadine Andrew

Low Report

Form 4 Monopar Therapeutics For: Sep 30 Filed by: Cittadine Andrew

Report

10/2

03:04 pm

mnpr

Form 4 Monopar Therapeutics For: Sep 30 Filed by: Robinson Chandler

Low Report

Form 4 Monopar Therapeutics For: Sep 30 Filed by: Robinson Chandler

Report

9/26

03:54 pm

mnpr

Form 4 Monopar Therapeutics For: Sep 24 Filed by: Tactic Pharma LLC

Low Report

Form 4 Monopar Therapeutics For: Sep 24 Filed by: Tactic Pharma LLC

Report

9/24

08:59 pm

mnpr

Form SCHEDULE 13D/A Monopar Therapeutics Filed by: Tactic Pharma LLC

Medium Report

Form SCHEDULE 13D/A Monopar Therapeutics Filed by: Tactic Pharma LLC

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.